Triton Robotic Endoscopy Achieves 100% Cecal Intubation with No Adverse Events in First-in-Human Study
First-in-Human Study of 50 Patients Shows Neptune Medical’s Triton Robotic Endoscopy System Achieves Zero Adverse Events and 100% Cecal Intubation in Colonoscopy Neptune Medical has reported encouraging results from its…
Niagen Bioscience Launches Niagen Plus Telehealth Platform with New At-Home Injection Kit Offering
Niagen Bioscience Unveils Niagen Plus Telehealth Platform with New At-Home Injection Kit Offering Niagen Bioscience (NASDAQ: NAGE), widely recognized for its leadership in NAD+ (nicotinamide adenine dinucleotide) research and its…
Alnylam Pharmaceuticals to Showcase New Analyses at Heart Failure 2026 Highlighting Consistent Clinical Profile of Vutrisiran in ATTR-CM
Alnylam Pharmaceuticals to Showcase New Analyses at Heart Failure 2026 Highlighting the Consistent Clinical Profile of Vutrisiran in ATTR-CM Alnylam Pharmaceuticals (Nasdaq: ALNY) has announced that it will present a…
Spruce Biosciences Bolsters Commercial Leadership with Appointments of Brian Walls and Darren Johnson
Spruce Biosciences Bolsters Commercial Leadership with Appointment of Brian Walls as VP, Market Access, and Darren Johnson as VP, Commercial Operations Spruce Biosciences, a late-stage biopharmaceutical company focused on developing…
Armatus Launches Scalable Potency Assay Platform to Advance Next-Generation Gene Silencing Therapies
Armatus Unveils Scalable Potency Assay Platform to Advance Next-Generation Gene Silencing Therapies Armatus Bio, a late-preclinical biotechnology company focused on developing vectorized RNA interference (RNAi) therapies for neuromuscular disorders, has…
OpRegen® 3-Year GA Data Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026
OpRegen® 3-Year Data in Geographic Atrophy Patients Showcased at Foundation Fighting Blindness Retinal Innovation Summit 2026 Lineage Cell Therapeutics (NYSE American and TASE: LCTX), a clinical-stage biotechnology company focused on…
Rejoni Names MedTech Veteran John Nealon as Chief Executive Officer to Lead Women’s Health Innovation
Rejoni Names John Nealon as Chief Executive Officer to Lead Its Women’s Health MedTech Strategy Rejoni Inc., a privately held clinical-stage biotechnology company focused on advancing uterine health through innovative…
Takeda Pharmaceutical Company Reports Positive Topline Data from Pivotal Phase 2/3 Trial of TAK-881 in Primary Immunodeficiency Disease
Takeda Pharmaceutical Company Reports Positive Topline Results from Pivotal Phase 2/3 Study of TAK-881 in Primary Immunodeficiency Disease Takeda Pharmaceutical Company (TSE:4502/NYSE:TAK) has reported positive topline results from its pivotal…
Assertio Enters into Revised and Restated Merger Agreement with Garda Therapeutics
Assertio Enters into Revised and Restated Merger Agreement with Garda Therapeutics Assertio Holdings has announced a significant update to its pending acquisition by Garda Therapeutics, revealing that the two companies…
Sensome Study Demonstrates First Accurate Detection of Clot Composition in Fully Blocked Brain Vessels
New Study Demonstrates Sensome’s Clot-Sensing Guidewire Precisely Identifies Clot Composition in Fully Occluded Brain Vessels for the First Time Sensome, a biotechnology innovator specializing in microsensing technology for real-time intra-operative…
Satellite Bio Secures U.S. Food and Drug Administration Rare Pediatric Disease Designation for SB-101 in Urea Cycle Disorders
Satellite Bio Secures U.S. Food and Drug Administration Rare Pediatric Disease Designation for SB-101 in Urea Cycle Disorders Satellite Biosciences has announced a significant regulatory milestone, revealing that the U.S.…
Ironwood Survey at DDW 2026 Highlights Need for Better Therapies to Reduce TPN Burden in SBS
Ironwood Presents Survey Data at DDW 2026 Highlighting Urgent Need for Treatments Addressing the Multifaceted Burden of Total Parenteral Nutrition in Short Bowel Syndrome Ironwood Pharmaceuticals, a biotechnology company focused…